UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
Current Report Pursuant
to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 28, 2016
Senomyx, Inc.
(Exact name of registrant as specified in its charter)
|
Delaware (State or other jurisdiction of incorporation) |
000-50791 (Commission File Number) |
33-0843840 (I.R.S. Employer Identification No.) |
|
4767 Nexus Centre Drive (Address of principal executive offices) |
92121 (Zip Code) |
Registrant's telephone number, including area code: (858) 646-8300
Not Applicable.
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 1.01 Entry into a Material Definitive Agreement
On July 28, 2016, we entered into a Letter Agreement with PepsiCo, Inc. to extend the research period under our Collaborative Research, Development, Commercialization and License Agreement dated August 16, 2010, as last amended on March 31, 2014, for an additional forty-five (45) days, through September 30, 2016. Except for this extension, all other terms and conditions of the Collaboration Agreement remain unchanged and continue in full force and effect.
Under the Letter Agreement, PepsiCo and Senomyx have agreed to use best efforts to negotiate in good faith the definitive terms of a longer extension of our current collaboration agreement. During this interim forty-five (45) day period, Senomyx will continue to receive funding from PepsiCo at the same rate provided under the current Collaboration Agreement.
Forward Looking Statement
Statements contained in this Form 8-K regarding matters that are not historical facts are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. While discussions between Senomyx and PepsiCo are underway, there can be no assurance that any extension agreement will be reached on favorable terms, or at all, or that any collaboration agreement will be on the terms that are currently being discussed. This and other risks and uncertainties are described more fully in our most recently filed SEC documents, including our most recent Quarterly Report on Form 10-Q and Annual Report on Form 10-K, under the headings “Risks Related to Our Business” and “Risks Related to Our Industry.” All forward-looking statements contained herein speak only as of the date on which they were made. We undertake no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
SENOMYX, INC. | |
|
|
|
|
|
|
By: |
/S/ CATHERINE LEE |
|
|
|
Catherine Lee |
|
|
|
Vice President, General Counsel and Corporate Secretary |
|
|
|
|
|
Date: July 28, 2016 |
|
|